These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. Chaisson RE, Moore RD, Richman DD, Keruly J, Creagh T. Am Rev Respir Dis; 1992 Aug; 146(2):285-9. PubMed ID: 1362634 [Abstract] [Full Text] [Related]
6. Effects of recombinant human granulocyte colony-stimulating factor on leucopenia in zidovudine-treated patients with AIDS and AIDS related complex, a phase I/II study. van der Wouw PA, van Leeuwen R, van Oers RH, Lange JM, Danner SA. Br J Haematol; 1991 Jul; 78(3):319-24. PubMed ID: 1714756 [Abstract] [Full Text] [Related]
8. Toxic effects of zidovudine in asymptomatic human immunodeficiency virus-infected individuals with CD4+ cell counts of 0.50 x 10(9)/L or less. Detailed and updated results from protocol 019 of the AIDS Clinical Trials Group. Koch MA, Volberding PA, Lagakos SW, Booth DK, Pettinelli C, Myers MW. Arch Intern Med; 1992 Nov; 152(11):2286-92. PubMed ID: 1359846 [Abstract] [Full Text] [Related]
9. Zidovudine for the treatment of thrombocytopenia associated with human immunodeficiency virus (HIV). A prospective study. The Swiss Group for Clinical Studies on the Acquired Immunodeficiency Syndrome (AIDS). Ann Intern Med; 1988 Nov 01; 109(9):718-21. PubMed ID: 3190058 [Abstract] [Full Text] [Related]
12. Zidovudine for treating AIDS. What physicians need to know. Amin NM. Postgrad Med; 1989 Jul 01; 86(1):195-6, 201-8. PubMed ID: 2662155 [Abstract] [Full Text] [Related]
13. Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group. Fischl MA, Richman DD, Causey DM, Grieco MH, Bryson Y, Mildvan D, Laskin OL, Groopman JE, Volberding PA, Schooley RT. JAMA; 1989 Nov 03; 262(17):2405-10. PubMed ID: 2677429 [Abstract] [Full Text] [Related]
14. Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group. McKinney RE, Pizzo PA, Scott GB, Parks WP, Maha MA, Lehrman SN, Riggs M, Eddy J, Lane BA, Eppes SC. J Pediatr; 1990 Apr 03; 116(4):640-7. PubMed ID: 2181102 [Abstract] [Full Text] [Related]
16. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group. Chaisson RE, Keruly J, Richman DD, Moore RD. Arch Intern Med; 1992 Oct 03; 152(10):2009-13. PubMed ID: 1417373 [Abstract] [Full Text] [Related]
20. Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS). Krown SE, Gold JW, Niedzwiecki D, Bundow D, Flomenberg N, Gansbacher B, Brew BJ. Ann Intern Med; 1990 Jun 01; 112(11):812-21. PubMed ID: 1971504 [Abstract] [Full Text] [Related] Page: [Next] [New Search]